Pediatric renal cell carcinoma

Journal of Pediatric Urology

Volumn 5, Issue 4, 2009, Pages 308-314

  Sausville, Justin E ^a   Hernandez, David J ^a   Argani, Pedram ^a   Gearhart, John P ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

MiT; Pediatric renal cell carcinoma; Second malignancy; TFE3; Translocation RCC

Indexed keywords

ALPHA INTERFERON; BEVACIZUMAB; DOXORUBICIN; INTERLEUKIN 2; PROTEIN TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR;

ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CYTOGENETICS; DRUG MEGADOSE; GENE TRANSLOCATION; HUMAN; HYPERTHERMIA; KIDNEY CARCINOMA; LYMPH NODE DISSECTION; NEPHRECTOMY; NEPHRON SPARING SURGERY; PRIORITY JOURNAL;

CARCINOMA, RENAL CELL; CHILD; HUMANS; KIDNEY NEOPLASMS; NEOPLASMS, SECOND PRIMARY; TRANSLOCATION, GENETIC;

EID: 70149118335     PISSN: 14775131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpurol.2009.04.007     Document Type: Article

References (45)

1. Selle B., Furtwängler R., Graf N., Kaatsch P., Bruder E., and Leuschner I. Population-based study of renal cell carcinoma in children in Germany, 1980-2005. More frequently localized tumors and underlying disorders compared with adult counterparts. Cancer 107 (2006) 2906-2914
2. Silberstein J., Grabowski J., Saltzstein S.L., and Kane C.J. Renal cell carcinoma in the pediatric population: results from the California cancer registry. Pediatr Blood Cancer 52 (2009) 237-241
3. Bassal M., Mertens A.C., Taylor L., Neglia J.P., Greffe B.S., Hammond S., et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24 (2006) 476-483
4. Fleitz J.M., Wootton-Gorges S.L., Wyatt-Ashmead J., McGavran L., Koyle M., West D.C., et al. Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood. Pediatr Radiol 33 (2003) 540-545
5. Schafernak K.T., Yang X.J., Hsueh W., Leestma J.L., Stagl J., and Goldman S. Pediatric renal cell carcinoma as second malignancy: reports of two cases and review of the literature. Can J Urol 14 (2007) 3739-3744
6. Dhall D., Al-Ahmadie H.A., Dhall G., Shen-Schwarz S., and Tickoo S.K. Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyosarcoma. Urology 70 (2007) 178.e13-178.e15
7. Argani P., Laé M., Ballard E.T., Amin M., Manivel C., Hutchinson B., et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol 24 (2006) 1530-1534
8. DeLair S.M., White R.W., and Kurzrock E.A. Secondary transitional cell carcinoma and nitrogen mustard treatment. Urology 65 (2005) 1226-1227
9. Medeiros L.J., Palmedo G., Krigman H.R., Kovacs G., and Beckwith J.B. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol 23 (1999) 772-780
10. Kirkali Z., Algaba F., Scarpelli M., Trias I., Selvaggi F.P., and Van Poppel H. What does the urologist expect from the pathologist (and what can the pathologist give) in reporting on adult kidney tumor specimens?. Eur Urol 51 (2007) 1194-1201
11. Indolfi P., Terenziani M., Casale F., Carli M., Bisogno G., Schiavetti A., et al. Renal cell carcinoma in children: a clinicopathologic study. J Clin Oncol 21 (2003) 530-535
12. Cook A., Lorenzo A.J., Pippi Salle J.L., Bakhshi M., Cartwright L.M., Bagi D., et al. Pediatric renal cell carcinoma: single institution 25-year case series and initial experience with partial nephrectomy. J Urol 175 (2006) 1456-1460
13. Estrada C.R., Suthar A.M., Eaton S.H., and Cilento B.G. Renal cell carcinoma: Children's Hospital Boston experience. Urology 66 (2005) 1296-1300
14. Labanaris A.P., Schott G.E., and Zugor V. Renal cell carcinoma in children under 10 years old: a presentation of four cases. Pediatr Surg Int 23 (2007) 327-330
15. Bosquet M., Domínguez C., Balaguer J., Serrano A., Estornell F., Martínez-Verduch M., et al. Pediatric renal adenocarcinoma: a review of our series. Urology 72 (2008) 790-793
16. Tsai H.L., Chin T.W., Chang J.W., Liu C.S., and Wei C.F. Renal cell carcinoma in children and young adults. J Chin Med Assoc 69 (2006) 240-244
17. Geller J.I., and Dome J.S. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer 101 (2004) 1575-1583
18. Luciani L.G., Cestari R., and Tallarigo C. Incidental renal cell carcinoma - age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology 56 (2000) 58-62
19. Kane C.J., Mallin K., Ritchey J., Cooperberg M.R., and Carroll P.R. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113 (2008) 78-83
20. Miniati D., Gay A.N., Parks K.V., Naik-Mathuria B.J., Hicks J., Nuchtern J.G., et al. Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children. J Pediatr Surg 43 (2008) 1301-1307
21. Renshaw AA, Granter SR, Fletcher JA, Kozakewich HP, Corless CL, Perez-Atayde AR. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol 1999;23:795-802.
22. Suzigan S., Drut R., Faria P., Argani P., DeMarzo A.M., Barbosa R.N., et al. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features. Int J Surg Pathol 15 (2007) 199-203
23. Wallis M.C., Lorenzo A.J., Farhat W.A., Bägli D.J., Khoury A.E., and Pippi Salle J.L. Risk assessment of incidentally detected complex renal cysts in children: potential role for a modification of the Bosniak classification. J Urol 180 (2008) 317-321
24. Israel G.M., and Bosniak M.A. An update of the Bosniak renal cyst classification system. Urology 66 (2005) 484-488
25. Carcao M.D., Taylor G.P., Greenberg M.L., Bernstein M.L., Champagne M., Hershon L., et al. Renal-cell carcinoma in children: a different disorder from its adult counterpart?. Med Pediatr Oncol 31 (1998) 153-158
26. Ramphal R., Pappo A., Zielenska M., Grant R., and Ngan B.-Y. Clinical, pathologic, and molecular abnormalities associated with the members of the MiT transcription factor family. Am J Clin Pathol 126 (2006) 349-364
27. Argani P., and Ladanyi M. The evolving story of renal translocation carcinomas. Am J Clin Pathol 126 (2006) 332-334
28. Argani P., and Ladanyi M. Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas. Pathology 35 (2003) 492-498
29. Argani P., and Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med 25 (2005) 363-378
30. Argani P., Lui M.Y., Couturier J., Bouvier R., Fournet J.C., and Ladanyi M. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 22 (2003) 5374-5378
31. Medendorp K., van Groningen J.J.M., Schepens M., Vreede L., Thijssen J., Schoenmakers E.F.P.M., et al. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas. Cytogenet Genome Res 118 (2007) 157-165
32. Tsuda M., Davis I.J., Argani P., Shukla N., McGill G.G., Nagai M., et al. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res 67 (2007) 919-929
33. Argani P., Laé M., Hutchinson B., Reuter V.E., Collins M.H., Perentesis J., et al. Renal carcinomas with the t(6;11)(p21;q12). Am J Surg Pathol 29 (2005) 230-240
34. Meyer P.N., Clark J.I., Flanigan R.C., and Picken M.M. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am J Clin Pathol 128 (2007) 70-79
35. Argani P, Olgac S, Tickoo SK, Goldfischer M, Moch H, Chan DY, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 2007;31:1149-60.
36. Russo P. Partial nephrectomy achieves local tumor control and prevents chronic kidney disease. Expert Rev Anticancer Ther 6 (2006) 1745-1751
37. Pantuck A.J., Zisman A., Dorey F., Chao D.F., Han K.R., Said J., et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 169 (2003) 2076-2083
38. Indolfi P., Bisogno G., Cecchetto G., Spreafico F., de Salvo G.L., Collini P., et al. Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP Project. Pediatr Blood Cancer 51 (2008) 475-478
39. Geller J.I., and Dome J.S. Retroperitoneal lymph node dissection for pediatric renal cell carcinoma. Pediatr Blood Cancer 52 (2009) 430
40. Geller J.I., Argani P., Adeniran A., Hampton E., De Marzo A., Hicks J., et al. Translocation renal carcinoma: lack of negative impact due to lymph node spread. Cancer 112 (2008) 1607-1616
41. Rais-Bahrami S., Drabick J.J., DeMarzo A.M., Hicks J., Ho C., Caroe A.E., et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology 70 (2007) 178.e3-178.e6
42. Ismail-Zade R.S., Zhavrid E.A., and Potapnev M.P. Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma. Pediatr Blood Cancer 44 (2005) 679-681
43. Bauer M., Reaman G.H., Hank J.A., Cairo M.S., Anderson P., Blazar B.R., et al. A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Children's Cancer Group Study. Cancer 75 (1995) 2959-2965
44. Thomas A.A., Rini B.I., Lane B.R., Garcia J., Dreicer R., Klein E.A., et al. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. J Urol 181 (2009) 518-523
45. Joshi D.D., and Banerjee T. Vascular endothelial growth factor (VEGF) receptor antibody bevacizumab (avastin) induces regression of renal cell carcinoma in an adolescent resulting in residual tumorectomy. Pediatr Blood Cancer 50 (2007) 903-904